VolitionRX Limited Common Stock

(AMEX: VNRX)
4.61 0.36 8.47%
Stock Price | Dec. 6, 2019, 3:59 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 4.25
52 Week Low: 1.67
52 Week High: 6.84
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Read more Read less

Recently Viewed Tickers